Olanzapine versus propranolol in essential tremor

Clinical Neurology and Neurosurgery

Volumn 108, Issue 1, 2005, Pages 32-35

  Yetimalar, Yeşim ^a   Irtman, Gülümser ^a   Kurt, Tülay ^a   Başog̀lu, Mustafa ^a  

^a ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Essential tremor; Olanzapine; Propranolol

Indexed keywords

OLANZAPINE; PROPRANOLOL;

ADULT; AGED; ANOREXIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DROWSINESS; DRUG EFFICACY; ESSENTIAL TREMOR; EVALUATION; FATIGUE; FEMALE; HUMAN; IMPOTENCE; MALE; NAUSEA; RANDOMIZED CONTROLLED TRIAL; SEDATION; SELF REPORT; SIDE EFFECT; STATISTICAL ANALYSIS; STOMACH DISEASE;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; AGED, 80 AND OVER; BENZODIAZEPINES; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ESSENTIAL TREMOR; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROPRANOLOL; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 28444492051     PISSN: 03038467     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clineuro.2005.01.002     Document Type: Article

References (20)

1. L.J. Findley, and W.C. Koller Essential tremor: a review Neurology 37 1987 1194 1197
2. L.J. Findley Tremors: differential diagnosis and pharmacology J. Jankovic E. Tolosa Parkinson's disease and movement disorders 1993 Williams & Wilkins Baltimore 293 313
3. Findley LJ, Koller WC, Le Witt P. Classification and definition of tremor. In: Lord Walton of Detchan, ed. Indications for and clinical implications of botulinum toxin therapy. Royal Society of Medicine, London; 1993. p. 22-3.
4. J. Jankovic, F. Cordoso, and R. Grossman Outcome after stereotaxic thalamotomy for parkinsonism, essential, and other types tremor Neurosurgery 37 1995 680 687
5. W.C. Koller, R. Pahwa, and K. Busenbark High-frequency unilateral thalamic stimulation in the treatment of essential and parkinsonian tremor Ann Neurol 42 1997 292 299
6. M. Mohadjer, H. Goerke, and E. Milios Long-term results of stereotaxy in the treatment of essential tremor Stereotact Funct Neurosurg 45 1990 125 129
7. W.C. Koller, and G. Deuschl Essential tremor Neurology 54 2000 2 45
8. R. Ceravolo, S. Savletti, and P. Piccini Acute and chronic effects of clozapine in essential tremor Mov Disord 14 1999 468 472
9. J.H. Friedman, W.C. Koller, and M.C. Lannon Benztropine versus clozapine for the treatment of tremor in Parkinson's disease Neurology 48 1997 1077 1081
10. U. Bonuccelli, R. Ceravolo, and S. Savletti Clozapine in Parkinson's disease tremor: effects of acute and chronic administration Neurology 49 1997 1587 1590
11. F. Delecluse, J.A. Elosegi, and J.M. Gerard A case of tardive tremor successfully treated with clozapine Mov Disord 13 1998 846 847
12. H. Pakkenberg, and B. Pakkenberg Clozapine in the treatment of tremor Acta Neurol Scand 73 1986 295 297
13. H.Y. Meltzer An overview of the mechanism of action of clozapine J Clin Psychiatry 55 1994 47 52
14. P.V. Taran Olanzapine, a novel antipsychotic Williams & Wilkins healthcare 2000 112 114
15. R.L. Watts, and W.C. Koller Movement disorders. Neurologic principles and practice 1997 McGraw-Hill Companies New York pp. 366-81
16. W.C. Koller, A. Hristova, and M.O. Brin Pharmacologic treatment of essential tremor Neurol 54 2000 30 38
17. J.J. Caro, A. Ward, C. Levinton, and K. Robinson The risk of diabetes during olanzapine use compared with risperidone use: a retrospective database analysis J Clin Psychiatry 63 12 2002 1135 1139
18. Bobes J, Rejas J, Garcia-Garcia M, Rico-Villademoros F, Garca-Portilla MP, Fernandez I, et al. Weight gain in patients with schizophrenia treated with risperidone, olanzapine, quetiapine or haloperidol: results of the EIRE study. Schizophrenia Research, Elsevier Sci 62;2003:77-88.
19. D.W. Hedges, and K.G. Jeppson New-onset seizure associated with quetiapine and olanzapine Ann Pharmacother 36 3 2002 437 439
20. Y. Yetimalar, G. Irtman, N. Gurgor, and M. Basoglu Olanzapine efficacy in the treatment of essential tremor Eur J Neurol 10 2003 79 82